Evox Therapeutics, an exosome therapeutics company, has published Evox-funded research identifying novel exosome scaffold proteins that significantly improve drug loading into exosomes for therapeutic purposes in Nature Communications. This follows a research collaboration and option agreement with the Icahn School of Medicine at Mount Sinai to develop exosome-encapsulated AAV (exoAAV) vectors as a novel gene […]
